On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
We are very excited to launch our new website! Please take a few moments to click around and explore...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...